X0508 4 2025-10-31 0000862692 CRYO CELL INTERNATIONAL INC CCEL 0001315416 PORTNOY DAVID 700 BROOKER CREEK BLVD SUITE 1800 OLDSMAR FL 34677 true true true false Chairman, Co-CEO false Common Stock 2025-10-31 4 A false 4666 4.45 A 832010 D Common Stock 2025-11-04 4 A false 5000 4.40 A 837010 D Common Stock 161833 I By Corporation Common Stock 164182 I By 401K Common Stock 268878 I By IRA Common Stock 107403 I By Spouse Common Stock 11537 I As Custodian for son Common Stock 11398 I As Custodian for son Common Stock 10939 I As Custodian for son Common Stock 57306 I By Corporation Common Stock 59027 I By LLC Stock Option 7.53 2019-08-30 2029-08-30 Common stock 26243 26243 D Stock Option 7.28 2019-12-20 2029-12-20 Common Stock 23636 23636 D Stock Option 12.27 2021-12-22 2028-12-22 Common Stock 280000 280000 D Stock Option 4.77 2023-01-03 2028-01-03 Common Stock 50000 50000 D Stock Option 4.3 2022-12-23 2027-12-23 Common Stock 50000 50000 D Stock Option 6.47 2023-12-22 2028-12-22 Common Stock 50000 50000 D Stock Option 8.08 2025-01-21 2030-01-21 Common Stock 50000 50000 D The price reported is a weighted average price of $4.40. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary. Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership. Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term. 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026. Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. /s/ David Portnoy 2025-11-04